SCHEMBL30842640

SCHEMBL30842640

CCCCCCCCC(CCCCCC)COC(=O)CCCCC(CCCCC(=O)OC(CCCCCC)CSCCCCCC)NCCCCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TLR2 O60603 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30837891 0.94 TLR2 (0.39) TLR2
SCHEMBL30837985 0.94 TLR2 (0.39) TLR2
SCHEMBL30837944 0.94 TLR2 (0.39) TLR2
SCHEMBL30977723 0.94 TLR2 (0.39) TLR2
SCHEMBL30837942 0.94 TLR2 (0.39) TLR2
SCHEMBL30837979 0.94 TLR2 (0.39) TLR2
SCHEMBL30838052 0.94 TLR2 (0.39) TLR2
SCHEMBL30837973 0.94 TLR2 (0.39) TLR2
SCHEMBL30977705 0.94 TLR2 (0.39) TLR2
SCHEMBL30842647 0.92 TLR2 (0.40) TLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594300-A1 SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS Nanovation Therapeutics Inc. (CA) 2025-08-06 — — EP disclosed
WO-2024065041-A1 SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS NANOVATION THERAPEUTICS INC. (CA) 2024-04-04 — — WO disclosed
Send feedback